Redwood City, CA, United States of America

Mark Alfenito


 

Average Co-Inventor Count = 1.9

ph-index = 1

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2002-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mark Alfenito: Innovator in Influenza Vaccine Development

Introduction

Mark Alfenito is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of medical research, particularly in the development of vaccines. With a total of 3 patents to his name, Alfenito's work focuses on innovative solutions to combat influenza virus infections.

Latest Patents

One of Alfenito's latest patents is centered around an influenza vaccine and therapy. This invention is directed towards M1 polypeptides that can be utilized as vaccines and/or antigens. These polypeptides are designed for the generation of anti-M1 polypeptide antibodies, which are crucial for the prophylactic treatment of individuals susceptible to influenza virus infections. The anti-M1 polypeptide antibodies developed through this invention are beneficial for treating individuals already infected with the influenza virus. They also serve as a preventive measure for those who are at risk of infection, including immune-suppressed individuals who may not be able to generate an effective antibody response.

Career Highlights

Throughout his career, Mark Alfenito has worked with various companies, including Engen Bio, Inc. and Hyseq, Inc. His experience in these organizations has contributed to his expertise in vaccine development and medical research.

Collaborations

Alfenito has collaborated with notable coworkers such as Mark Baer and Doris Bucher. These partnerships have likely enhanced his research efforts and innovation in the field.

Conclusion

Mark Alfenito stands out as an influential inventor in the realm of influenza vaccine development. His contributions through patents and collaborations reflect his commitment to advancing medical science and improving public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…